跳至主要内容
临床试验/NCT03251027
NCT03251027进行中(未招募)不适用

Intensity-Modulated Stereotactic Radiotherapy as an Upfront Scalp-Sparing Intervention for the Treatment of Newly Diagnosed Grade II-IV Gliomas

Sidney Kimmel Cancer Center at Thomas Jefferson University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年7月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
1
主要终点
Incidence of wound infection or wound dehiscence

研究概览

简要总结

This phase II trial studies how well intensity-modulated stereotactic radiation therapy works in treating patients with grade II-IV glioma. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue.

详细描述

PRIMARY OBJECTIVES:

I. To determine the effect of intensity-modulated (IM)-stereotactic radiotherapy (SRT) on the incidence of wound infection (requiring oral/intravenous [IV] antibiotics or surgery), or wound dehiscence.

SECONDARY OBJECTIVES:

I. To determine the effect of IM-SRT on the incidence of titanium implants as palpable cranial defects due to scalp thinning.

II. To determine the effect of IM-SRT on the incidence of hair loss and recovery rate.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must have histologically confirmed low or high grade glioma (grade II-IV)
  • Karnofsky performance status (KPS) >= 60
  • Patients must have recovered from the effects of surgery; there must be a minimum of 21 days from the day of surgery to the day of protocol treatment
  • Estimated survival >= 3 months
  • Labs considered acceptable per standard of care
  • Patient must sign a study specific informed consent form
  • Radiation treatment must begin >= 3 weeks and =< 8 weeks after surgery

排除标准

  • Prior history of scalp radiation or intolerance to standard course of radiation treatment
  • Co-morbidities that would influence wound healing including diabetes (insulin dependent) or smoking (current ongoing use)
  • Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception
  • Karnofsky performance status (KPS) < 60
  • Patient can't have magnetic resonance imaging (MRI) scan
  • Active collagen vascular disease

研究组 & 干预措施

Treatment (IM-SRT)

Experimental

Patients undergo intensity-modulated (IM)-stereotactic radiotherapy (SRT) daily over 6 weeks.

干预措施: Intensity-Modulated Radiation Therapy (Radiation)

Treatment (IM-SRT)

Experimental

Patients undergo intensity-modulated (IM)-stereotactic radiotherapy (SRT) daily over 6 weeks.

干预措施: Quality-of-Life (Other)

结局指标

主要结局

Incidence of wound infection or wound dehiscence

时间窗: Up to 2 years

Will assess the impact of intensity-modulated stereotactic radiotherapy (IM-SRT) on the incidence of wound infection, or wound dehiscence.

次要结局

  • Incidence of titanium implants(Up to 2 years)
  • Incidence of hair loss(Up to 2 years)
  • Quality of life using European Quality of Life Five Dimension Five Level Scale Questionnaire(Up to 2 years)
  • Incidence of recovery rate(Up to 2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验